These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 19158317

  • 21. Rosuvastatin improves pulse wave reflection by restoring endothelial function.
    Ott C, Schneider MP, Schlaich MP, Schmieder RE.
    Microvasc Res; 2012 Jul; 84(1):60-4. PubMed ID: 22484031
    [Abstract] [Full Text] [Related]

  • 22. Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.
    Kostapanos MS, Milionis HJ, Filippatos TD, Christogiannis LG, Bairaktari ET, Tselepis AD, Elisaf MS.
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):5-13. PubMed ID: 19246334
    [Abstract] [Full Text] [Related]

  • 23. Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia.
    Matsuo T, Iwade K, Hirata N, Yamashita M, Ikegami H, Tanaka N, Aosaki M, Kasanuki H.
    Heart Vessels; 2005 Feb; 20(1):8-12. PubMed ID: 15700196
    [Abstract] [Full Text] [Related]

  • 24. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
    Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, Wang SY, Hung A, Cherng WJ.
    Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
    [Abstract] [Full Text] [Related]

  • 25. Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.
    Mackie BD, Satija S, Nell C, Miller J, Sperling LS.
    Am J Cardiol; 2007 Jan 15; 99(2):291. PubMed ID: 17223437
    [Abstract] [Full Text] [Related]

  • 26. Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg.
    Brunetti ND, Maulucci G, Casavecchia GP, Distaso C, De Gennaro L, Pellegrino PL, Di Biase M.
    J Interv Cardiol; 2007 Dec 15; 20(6):481-7. PubMed ID: 18042053
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatin.
    Goldberg AS, DeGorter MK, Ban MR, Kim RB, Hegele RA.
    Can J Cardiol; 2013 Aug 15; 29(8):915-9. PubMed ID: 23465343
    [Abstract] [Full Text] [Related]

  • 28. Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice.
    Li W, Asagami T, Matsushita H, Lee KH, Tsao PS.
    J Pharmacol Exp Ther; 2005 May 15; 313(2):557-62. PubMed ID: 15665143
    [Abstract] [Full Text] [Related]

  • 29. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
    Settergren M, Böhm F, Rydén L, Pernow J.
    Eur Heart J; 2008 Jul 15; 29(14):1753-60. PubMed ID: 18441323
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K, Klaey M, Burow A, Shaw SG, Hess OM, Allemann Y.
    Cardiovasc Ther; 2012 Oct 15; 30(5):277-86. PubMed ID: 21884007
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
    Kjekshus J, Dunselman P, Blideskog M, Eskilson C, Hjalmarson A, McMurray JV, Waagstein F, Wedel H, Wessman P, Wikstrand J, CORONA Study Group.
    Eur J Heart Fail; 2005 Oct 15; 7(6):1059-69. PubMed ID: 16227145
    [Abstract] [Full Text] [Related]

  • 35. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
    Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ.
    Am J Cardiol; 2008 Feb 01; 101(3):315-8. PubMed ID: 18237592
    [Abstract] [Full Text] [Related]

  • 36. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M, Averna M, Missault L, Vaverkova H, Viigimaa M, Massaad R, Vandormael K, Johnson-Levonas AO, Brudi P.
    Int J Clin Pract; 2009 Apr 01; 63(4):547-59. PubMed ID: 19222610
    [Abstract] [Full Text] [Related]

  • 37. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.
    Coen PM, Flynn MG, Markofski MM, Pence BD, Hannemann RE.
    Metabolism; 2009 Jul 01; 58(7):1030-8. PubMed ID: 19411087
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.
    Willich SN, Englert H, Sonntag F, Völler H, Meyer-Sabellek W, Wegscheider K, Windler E, Katus H, Müller-Nordhorn J.
    Eur J Cardiovasc Prev Rehabil; 2009 Apr 01; 16(2):180-7. PubMed ID: 19174696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.